Organogenesis Holdings Inc. (ORGO) News

Organogenesis Holdings Inc. (ORGO): $2.76

0.12 (-4.17%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Add ORGO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#28 of 363

in industry

Filter ORGO News Items

ORGO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ORGO News Highlights

  • For ORGO, its 30 day story count is now at 3.
  • Over the past 21 days, the trend for ORGO's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • TOP are the most mentioned tickers in articles about ORGO.

Latest ORGO News From Around the Web

Below are the latest news stories about ORGANOGENESIS HOLDINGS INC that investors may wish to consider to help them evaluate ORGO as an investment opportunity.

Organogenesis (ORGO) is a Great Momentum Stock: Should You Buy?

Does Organogenesis (ORGO) have what it takes to be a top stock pick for momentum investors? Let's find out.

Yahoo | December 28, 2023

Organogenesis Holdings Inc. (NASDAQ:ORGO) Surges 42% Yet Its Low P/S Is No Reason For Excitement

Organogenesis Holdings Inc. ( NASDAQ:ORGO ) shares have continued their recent momentum with a 42% gain in the last...

Yahoo | December 18, 2023

Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Stock Is Going Strong: Have Financials A Role To Play?

Organogenesis Holdings (NASDAQ:ORGO) has had a great run on the share market with its stock up by a significant 27...

Yahoo | December 7, 2023

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call Transcript

Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2023 Earnings Call Transcript November 9, 2023 Organogenesis Holdings Inc. beats earnings expectations. Reported EPS is $0.09075, expectations were $0.01. Operator: Welcome, ladies and gentlemen, to the Third Quarter of Fiscal Year 2023 Earnings Conference Call for Organogenesis Holdings Inc. [Operator Instructions]. Please note that this conference call is being […]

Yahoo | November 11, 2023

The recent US$46m market cap decrease is likely to have disappointed insiders invested in Organogenesis Holdings Inc. (NASDAQ:ORGO)

Key Insights Organogenesis Holdings' significant insider ownership suggests inherent interests in company's expansion...

Yahoo | November 10, 2023

Q3 2023 Organogenesis Holdings Inc Earnings Call

Q3 2023 Organogenesis Holdings Inc Earnings Call

Yahoo | November 10, 2023

Organogenesis (ORGO) Q3 2023 Earnings Call Transcript

Welcome, ladies and gentlemen, to the third quarter 2023 earnings conference call for Organogenesis Holdings Inc. At this time, all participants have been placed in a listen-only mode. Before we begin, I would like to remind everyone that our remarks today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made.

Yahoo | November 10, 2023

Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results

CANTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results for the third quarter ended September 30th, 2023. Third Quarter 2023 Financial Results Summary: Net revenue of $108.5 million for the third quarter of 2023, a decrease of $8.3 millio

Yahoo | November 9, 2023

12 Best Micro Cap Stocks To Invest In

In this piece, we will take a look at the 12 best micro cap stocks to invest in. To skip our introduction to micro cap investing, some benefits, and potential risks, you can skip ahead to 5 Best Micro Cap Stocks To Invest In. Depending on who you ask, it can be argued that the […]

Yahoo | October 30, 2023

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

CANTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that third quarter of fiscal year 2023 financial results will be reported after the market closes on Thursday, November 9th. Management will host a conference call at 5:00 p.m. Eastern Time on Novemb

Yahoo | October 5, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!